Logo

"We Think That's Poppycock"

Jul 27, 2009

Linda Avey from 23andMe appeared on CNBC's Healthy Horizons to discuss her company. The host asks Avey what she would say to critics who say the diseases arise from complex interactions of genes and environment and that what 23andMe provides is a small amount of information that could be misinterpreted. Avey replies: "We think that's poppycock. We think we should really be able to engage people directly."

H/T: The Genetic Genealogist

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.